GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program
GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.
GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.